ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 685

Sacroiliitis Misdiagnosed As Spondyloarthritis: Clinical Analysis of 581 Cases

Feng Huang, Yanyan Wang, Zheng Zhao and Jianglin Zhang, Rheumatology, Chinese PLA General Hospital, Beijing, China

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: differential diagnosis and spondylarthritis, MRI

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2015

Title: Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment Poster I: Clinical Aspects and Assessments

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: To study other disease conditions which can present with bone marrow edema of the sacroiliac joints mimicking spondyloarthritis(SpA).

Methods: In a retrospective study of 581 patients from January 2007 to January 2014 for inflammatory back pain datas, including clinical manifestations, laboratory examinations, imaging manifestations and sacroiliac joint biopsy pathological features of these patients were reviewed. All of these patients from Chinese PLA General Hospital. The Images were read independently by at least 2 experienced rheumatologists.

Results: Of the 581 patients, 455 (78.3%) were male, and 436 (75%) cases were diagnosed Ankylosing Spondylititis(AS)/SpA. HLA-B27 positivity rate was 87% among those diagnosed with AS/SpA, Among the 145 patients whose diagnosis was not AS/SpA, HLA-B27 positivity rate was only 8% in 145 patients. 46, 40 and 30 patients had an infectious etiology (pyogenic sacroiliitis/tuberculous infectious sacroiliitis/Brucellar infectious sacroiliitis), sclerosing osteitis or hypophosphatemia osteomalacia (HO) respectively. Other less common diagnoses included diffuse idiopathic bone hypertrophy, palmoplantar pustulosis arthritis and sacroiliac joint gout. The causes of HO included 15 cases of tumor-induced osteomalacia, 4 cases of long-term oral adefovir dipivoxil, 3 cases of Fanconi syndrome, 2 cases of hyperparathyroidism, 2 cases of Sjogren’s syndrome complicated with renal tubular acidosis. Patients with infectious sacroiliitis presented with MRI abnormalities which included bone marrow edema, erosion of bone and joint, 44 of the 46 patients who had an infectious sacroiliitis show adjacent muscle involvement in MRI.

Conclusion: Sacroiliitis not due to AS is quite common in daily practice.  Rheumatologists should suspect a different diagnosis when patients respond poorly to NSAIDs, have unexplained low grade fever or other clinical manifestations which cannot be fully explained by AS/SpA. This is even more important when making the decision of using anti-TNF therapy or other immunosuppressive agents.


Disclosure: F. Huang, None; Y. Wang, None; Z. Zhao, None; J. Zhang, None.

To cite this abstract in AMA style:

Huang F, Wang Y, Zhao Z, Zhang J. Sacroiliitis Misdiagnosed As Spondyloarthritis: Clinical Analysis of 581 Cases [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/sacroiliitis-misdiagnosed-as-spondyloarthritis-clinical-analysis-of-581-cases/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sacroiliitis-misdiagnosed-as-spondyloarthritis-clinical-analysis-of-581-cases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology